NCT05507333View on ClinicalTrials.gov

Clinical Performance of the Gedea Pessary in Adult Women With Vulvovaginal Candidiasis

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

March 16, 2023

Primary Completion Date

February 22, 2024

Study Completion Date

March 5, 2024

Conditions
Vulvovaginal Candidiasis
Interventions
DEVICE

pHyph generation II

Daily administration of the Gedea pessary during 6 days

Trial Locations (4)

75237

CTC MTC, Uppsala

405 45

Carlanderska, Gothenburg

141 86

KS Huddinge, Stockholm

182 88

Danderyds sjukhus, Stockholm

Sponsors

Lead Sponsor

Gedea Biotech AB
All Listed Sponsors
lead

Gedea Biotech AB

INDUSTRY